BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22301404)

  • 1. JAK/STAT signal pathway activation promotes progression and survival of human oesophageal squamous cell carcinoma.
    You Z; Xu D; Ji J; Guo W; Zhu W; He J
    Clin Transl Oncol; 2012 Feb; 14(2):143-9. PubMed ID: 22301404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation analysis of JAK-STAT pathway components on prognosis of patients with prostate cancer.
    Liu X; He Z; Li CH; Huang G; Ding C; Liu H
    Pathol Oncol Res; 2012 Jan; 18(1):17-23. PubMed ID: 21681602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical detection of phosphorylated JAK-2 and STAT-5 proteins and correlation with erythropoietin receptor (EpoR) expression status in human brain tumors.
    Kondyli M; Gatzounis G; Kyritsis A; Varakis J; Assimakopoulou M
    J Neurooncol; 2010 Nov; 100(2):157-64. PubMed ID: 20336349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of HSPA2 is correlated with poor prognosis in esophageal squamous cell carcinoma.
    Zhang H; Chen W; Duan CJ; Zhang CF
    World J Surg Oncol; 2013 Jun; 11():141. PubMed ID: 23777267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
    Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
    J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of Sirtuin-1 is associated with poor clinical outcome in esophageal squamous cell carcinoma.
    He Z; Yi J; Jin L; Pan B; Chen L; Song H
    Tumour Biol; 2016 Jun; 37(6):7139-48. PubMed ID: 26662958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the IL-6R/Jak/stat pathway is associated with a poor outcome in resected pancreatic ductal adenocarcinoma.
    Denley SM; Jamieson NB; McCall P; Oien KA; Morton JP; Carter CR; Edwards J; McKay CJ
    J Gastrointest Surg; 2013 May; 17(5):887-98. PubMed ID: 23435739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated expression of Rad51 is correlated with decreased survival in resectable esophageal squamous cell carcinoma.
    Li Y; Yu H; Luo RZ; Zhang Y; Zhang MF; Wang X; Jia WH
    J Surg Oncol; 2011 Nov; 104(6):617-22. PubMed ID: 21744352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DJ-1 could predict worse prognosis in esophageal squamous cell carcinoma.
    Yuen HF; Chan YP; Law S; Srivastava G; El-Tanani M; Mak TW; Chan KW
    Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3593-602. PubMed ID: 19064576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eukaryotic translation initiation factor 3B accelerates the progression of esophageal squamous cell carcinoma by activating β-catenin signaling pathway.
    Xu F; Xu CZ; Gu J; Liu X; Liu R; Huang E; Yuan Y; Zhao G; Jiang J; Xu C; Chu Y; Lu C; Ge D
    Oncotarget; 2016 Jul; 7(28):43401-43411. PubMed ID: 27270324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical significance and underlying correlation of pStat-3 and integrin αvβ6 expression in gallbladder cancer.
    Enyu L; Na W; Chuanzong Z; Ben W; Xiaojuan W; Yan W; Zequn L; Jianguo H; Jiayong W; Benjia L; Cheng P; Min Z; Zongli Z
    Oncotarget; 2017 Mar; 8(12):19467-19477. PubMed ID: 28061445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced expression of Raf-1 kinase inhibitory protein predicts regional lymph node metastasis and shorter survival in esophageal squamous cell carcinoma.
    Kim HS; Won KY; Kim GY; Kim SC; Park YK; Kim YW
    Pathol Res Pract; 2012 May; 208(5):292-9. PubMed ID: 22464151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of Sox3 is associated with diminished prognosis in esophageal squamous cell carcinoma.
    Li K; Wang RW; Jiang YG; Zou YB; Guo W
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S459-66. PubMed ID: 23238694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JAK2 inhibitor blocks the inflammation and growth of esophageal squamous cell carcinoma in vitro through the JAK/STAT3 pathway.
    Fang J; Chu L; Li C; Chen Y; Hu F; Zhang X; Zhao H; Liu Z; Xu Q
    Oncol Rep; 2015 Jan; 33(1):494-502. PubMed ID: 25405520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression and clinical significance of COX-2, p-Stat3, and p-Stat5 in esophageal carcinoma].
    Liu JR; Wang Y; Zuo LF; Li FL; Wang Y; Liu JL
    Ai Zheng; 2007 May; 26(5):458-62. PubMed ID: 17672932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of stromal caveolin-1 expression in esophageal squamous cell carcinoma: a potent predictor of lymph node metastases, early tumor recurrence, and poor prognosis.
    Jia Y; Wang N; Wang J; Tian H; Ma W; Wang K; Tan B; Zhang G; Yang S; Bai B; Cheng Y
    Ann Surg Oncol; 2014 Jan; 21(1):329-36. PubMed ID: 23982252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twist1 is an independent prognostic factor of esophageal squamous cell carcinoma and associated with its epithelial-mesenchymal transition.
    Lee KW; Kim JH; Han S; Sung CO; Do IG; Ko YH; Um SH; Kim SH
    Ann Surg Oncol; 2012 Jan; 19(1):326-35. PubMed ID: 21732143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced stratifin expression can serve as an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.
    Ren HZ; Pan GQ; Wang JS; Wen JF; Wang KS; Luo GQ; Shan XZ
    Dig Dis Sci; 2010 Sep; 55(9):2552-60. PubMed ID: 20108042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. κ-Opioid receptor in the nucleus is a novel prognostic factor of esophageal squamous cell carcinoma.
    Zhang YF; Xu QX; Liao LD; Xu XE; Wu JY; Shen J; Wu ZY; Shen JH; Li EM; Xu LY
    Hum Pathol; 2013 Sep; 44(9):1756-65. PubMed ID: 23574786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and clinical significance of C14orf166 in esophageal squamous cell carcinoma.
    Zhou YW; Li R; Duan CJ; Gao Y; Cheng YD; He ZW; Zeng JX; Zhang CF
    Mol Med Rep; 2017 Feb; 15(2):605-612. PubMed ID: 28000881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.